$12.65
0.191.52%
Pre-Market: Jul 16, 8:34 AM EDT
15 minutes delayed
Comments
Loading...
Avalo Therapeutics
AVTXNASDAQ
Avalo Therapeutics (NASDAQ:AVTX) Stock, Earnings Estimates, EPS, And Revenue
Avalo Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 5
EPS Estimate
$-6.700
Quarterly Revenue Estimate
–
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$1.4M
Analyze the earnings history of Avalo Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AVTX | Avalo Therapeutics | -$141.60 | -$6.70 | — | — | $643.00K | — | — | — | 08/05/2024 | Get Alert |
| AVTX | Avalo Therapeutics | -$204.00 | -$1.18 | -$6.11 | -417.80% | $475.00K | — | $0.00 | — | 05/13/2024 | Get Alert |
| AVTX | Avalo Therapeutics | -$249.60 | -$4.80 | -$10.12 | -110.83% | $896.00K | $300.00K | $571.00K | 90.33% | 03/29/2024 | Get Alert |
| AVTX | Avalo Therapeutics | $81.60 | -$264.00 | -$26.40 | 90.00% | $14.95M | $1.00M | $236.00K | -76.40% | 11/09/2023 | Get Alert |
| AVTX | Avalo Therapeutics | -$331.20 | -$192.00 | -$141.60 | 26.25% | $1.03M | $500.00K | $643.00K | 28.60% | 08/03/2023 | Get Alert |
| AVTX | Avalo Therapeutics | -$576.00 | -$232.80 | -$204.00 | 12.37% | $1.17M | $1.00M | $475.00K | -52.50% | 05/04/2023 | Get Alert |
| AVTX | Avalo Therapeutics | -$460.80 | -$175.20 | -$249.60 | -42.47% | $219.00K | $3.61M | $896.00K | -75.18% | 03/29/2023 | Get Alert |
| AVTX | Avalo Therapeutics | -$499.20 | -$261.60 | $81.60 | 131.19% | $1.35M | $1.08M | $14.95M | 1284.17% | 11/07/2022 | Get Alert |
| AVTX | Avalo Therapeutics | -$2.16 | -$424.80 | -$331.20 | 22.03% | $3.35M | $790.00K | $1.03M | 30.76% | 08/04/2022 | Get Alert |
| AVTX | Avalo Therapeutics | -$3.84 | -$374.40 | -$576.00 | -53.85% | $473.00K | $370.00K | $1.17M | 217.03% | 05/05/2022 | Get Alert |
| AVTX | Avalo Therapeutics | -$2.28 | — | -$460.80 | — | $1.50M | — | $219.00K | — | 03/02/2022 | Get Alert |
| AVTX | Avalo Therapeutics | -$1.92 | -$518.40 | -$489.60 | 5.56% | $1.11M | $1.12M | $1.35M | 20.54% | 11/09/2021 | Get Alert |
| AVTX | Avalo Therapeutics | -$2.16 | -$1.92 | -$2.16 | -12.50% | $1.34M | $4.20M | $3.35M | -20.12% | 08/02/2021 | Get Alert |
| AVTX | Avalo Therapeutics | -$4.32 | -$1.92 | -$3.84 | -100.00% | $2.75M | $4.20M | $473.00K | -88.74% | 05/13/2021 | Get Alert |
| AVTX | Avalo Therapeutics | -$1.20 | — | -$2.28 | — | $3.44M | — | $1.50M | — | 03/08/2021 | Get Alert |
| AVTX | Avalo Therapeutics | -$0.84 | — | -$1.92 | — | $5.61M | — | $1.11M | — | 11/09/2020 | Get Alert |
| AVTX | Avalo Therapeutics | -$1.32 | — | -$2.16 | — | $4.45M | — | $1.34M | — | 08/06/2020 | Get Alert |
| AVTX | Avalo Therapeutics | -$1.56 | — | -$4.32 | — | $5.41M | — | $2.75M | — | 05/07/2020 | Get Alert |
| AVTX | Avalo Therapeutics | -$2.16 | $0.84 | -$1.20 | -242.86% | $4.98M | $12.41M | $3.44M | -72.27% | 03/11/2020 | Get Alert |
| AVTX | Avalo Therapeutics | -$2.04 | — | -$0.84 | — | $4.08M | — | $5.61M | — | 11/14/2019 | Get Alert |
| AVTX | Avalo Therapeutics | -$2.28 | — | -$1.32 | — | $4.79M | — | $4.45M | — | 08/08/2019 | Get Alert |
Avalo Therapeutics (AVTX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-13 | $-6.11 | $-1.18 | -417.8 % |
| Dec 2023 | 2024-03-29 | $-10.12 | $-4.80 | -110.8 % |
| Sep 2023 | 2023-11-09 | $-26.40 | $-264.00 | 90.0 % |
| Jun 2023 | 2023-08-03 | $-141.60 | $-192.00 | 26.3 % |
Avalo Therapeutics (AVTX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Dec 2023 | 2024-03-29 | $571.00K | $300.00K | 90.3 % |
| Sep 2023 | 2023-11-09 | $236.00K | $1.00M | -76.4 % |
| Jun 2023 | 2023-08-03 | $643.00K | $500.00K | 28.6 % |
| Mar 2023 | 2023-05-04 | $475.00K | $1.00M | -52.5 % |
FAQ
When is Avalo Therapeutics (NASDAQ:AVTX) reporting earnings?
Avalo Therapeutics (AVTX) is scheduled to report earnings on August 5, 2024. The last reported earnings were for reported on May 13, 2024 for Q1.
What were the latest earnings per share (EPS) for Avalo Therapeutics (NASDAQ:AVTX)?
The Actual EPS was $-6.11, which missed the estimate of $-1.18.
What were Avalo Therapeutics’s (NASDAQ:AVTX) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.